RB Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $736K | Sell |
10,535
-602
| -5% | -$42.1K | 0.17% | 102 |
|
|
2025
Q1 | $819K | Sell |
11,137
-817
| -7% | -$60K | 0.19% | 94 |
|
|
2024
Q4 | $783K | Sell |
11,954
-314
| -3% | -$20.6K | 0.18% | 92 |
|
|
2024
Q3 | $956K | Sell |
12,268
-186
| -1% | -$14.5K | 0.22% | 86 |
|
|
2024
Q2 | $971K | Buy |
12,454
+235
| +2% | +$18.3K | 0.24% | 73 |
|
|
2024
Q1 | $828K | Buy |
12,219
+1
| +0% | +$68 | 0.22% | 86 |
|
|
2023
Q4 | $823K | Buy |
12,218
+15
| +0.1% | +$1.01K | 0.24% | 79 |
|
|
2023
Q3 | $826K | Buy |
12,203
+56
| +0.5% | +$3.79K | 0.26% | 73 |
|
|
2023
Q2 | $869K | Sell |
12,147
-15
| -0.1% | -$1.07K | 0.26% | 75 |
|
|
2023
Q1 | $844K | Buy |
12,162
+115
| +1% | +$7.98K | 0.27% | 76 |
|
|
2022
Q4 | $817K | Buy |
12,047
+357
| +3% | +$24.2K | 0.29% | 74 |
|
|
2022
Q3 | $641K | Buy |
11,690
+2,064
| +21% | +$113K | 0.25% | 85 |
|
|
2022
Q2 | $636K | Buy |
9,626
+1,245
| +15% | +$82.3K | 0.24% | 84 |
|
|
2022
Q1 | $556K | Buy |
8,381
+151
| +2% | +$10K | 0.18% | 95 |
|
|
2021
Q4 | $479K | Buy |
8,230
+84
| +1% | +$4.89K | 0.15% | 117 |
|
|
2021
Q3 | $489K | Buy |
8,146
+50
| +0.6% | +$3K | 0.18% | 101 |
|
|
2021
Q2 | $485K | Hold |
8,096
| – | – | 0.18% | 103 |
|
|
2021
Q1 | $403K | Buy |
8,096
+544
| +7% | +$27.1K | 0.18% | 104 |
|
|
2020
Q4 | $378K | Hold |
7,552
| – | – | 0.17% | 101 |
|
|
2020
Q3 | $412K | Buy |
7,552
+351
| +5% | +$19.1K | 0.19% | 93 |
|
|
2020
Q2 | $381K | Buy |
7,201
+630
| +10% | +$33.3K | 0.2% | 93 |
|
|
2020
Q1 | $288K | Buy |
6,571
+4,612
| +235% | +$202K | 0.19% | 96 |
|
|
2019
Q4 | $281K | Sell |
1,959
-3,354
| -63% | -$481K | 0.16% | 107 |
|
|
2019
Q3 | $231K | Buy |
5,313
+390
| +8% | +$17K | 0.15% | 111 |
|
|
2019
Q2 | $203K | Sell |
4,923
-203
| -4% | -$8.37K | 0.15% | 115 |
|
|
2019
Q1 | $207K | Buy |
+5,126
| New | +$207K | 0.17% | 108 |
|